Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis/ Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07056569
What this trial is testing

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters

Who this might be right for
Dermatitis, ContactDermatitisDermatitis, Chronic+2 more
Biokosmes Srl 90
Post-approval studies (Phase 4)Study completedNCT00666159
What this trial is testing

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 226
Large-scale testing (Phase 3)Study completedNCT03908970
What this trial is testing

Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

Who this might be right for
Atopic Dermatitis
Otsuka Pharmaceutical Co., Ltd. 364
Not applicableUnknownNCT06189105
What this trial is testing

Efficacy and Safety Assessment of Niacinamide Cosmetic Preparation: a Randomized Controlled Trial

Who this might be right for
Skin HyperpigmentationDry Skin; Eczema
University of Split, School of Medicine 25
Testing effectiveness (Phase 2)Study completedNCT02324972
What this trial is testing

Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aquinox Pharmaceuticals (Canada) Inc. 54
Not applicableStudy completedNCT03397979
What this trial is testing

Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MaineHealth 63
Testing effectiveness (Phase 2)Study completedNCT04378569
What this trial is testing

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
Arcutis Biotherapeutics, Inc. 230
Not applicableStudy completedNCT01069666
What this trial is testing

Knowledge Base in the Treatment of Atopic Dermatitis Among Thai Pediatricians

Who this might be right for
Childhood Atopic Dermatitis
Siriraj Hospital
Large-scale testing (Phase 3)Study completedNCT02182570
What this trial is testing

WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

Who this might be right for
Dermatitis, Atopic
Boehringer Ingelheim 62
Post-approval studies (Phase 4)Study completedNCT00690105
What this trial is testing

Protopic Ointment in Adult Atopic Eczema of the Face

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 577
Not applicableWithdrawnNCT01045486
What this trial is testing

The Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk Allergy

Who this might be right for
Atopic Dermatitis
Soonchunhyang University Hospital 36
Not applicableStudy completedNCT00903357
What this trial is testing

The Effectiveness of Montelukast on Atopic Dermatitis in Koreans

Who this might be right for
Atopic Dermatitis
Pyun BokYang 54
Not applicableStudy completedNCT00102570
What this trial is testing

Clinical and Immunological Evaluation of Children With Allergies

Who this might be right for
Hypersensitivity, Immediate
National Institute of Allergy and Infectious Diseases (NIAID) 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT05769777
What this trial is testing

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 999
Early research (Phase 1)Study completedNCT07205081
What this trial is testing

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

Who this might be right for
Normal VolunteersAtopic Dermatitis (AD)Atopic Eczema+1 more
Attovia Therapeutics Inc 48
Post-approval studies (Phase 4)Study completedNCT02300701
What this trial is testing

Role of Anti-IgE in Severe Childhood Eczema

Who this might be right for
Atopic EczemaAtopic DermatitisChild
Guy's and St Thomas' NHS Foundation Trust 62
Large-scale testing (Phase 3)Study completedNCT03363854
What this trial is testing

Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3

Who this might be right for
Atopic Dermatitis
LEO Pharma 380
Not applicableLooking for participantsNCT04334031
What this trial is testing

Deployment o the Multidisciplinary Prospective Cohort Imminent

Who this might be right for
Chronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more
University Hospital, Lille 2,200
Testing effectiveness (Phase 2)Study completedNCT05607901
What this trial is testing

A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

Who this might be right for
Dermatologic Disease
Tanta University 100
Large-scale testing (Phase 3)Study completedNCT04587453
What this trial is testing

Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 106
Next Page